|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 31/282 | (2006.01) | ||
| A61K 31/555 | (2006.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 0943331 |
| (13) | Kind of document | T |
| (96) | European patent application number | 99301412.5 |
| Date of filing the European patent application | 1999-02-25 | |
| (97) | Date of publication of the European application | 1999-09-22 |
| (45) | Date of publication and mention of the grant of the patent | 2001-06-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 9804013 | 1998-02-25 | GB |
| (72) |
Anderson, Nicholas H., GB
Blundell, Ross, GB
Brown, Stephen, GB
England, David A., GB
Gray, Martin R., GB
|
| (73) |
SANOFI-SYNTHELABO,
174, Avenue de France, 75013 Paris,
FR
|
| (54) | Formulations containing oxaliplatin |
| Formulations containing oxaliplatin |